Swiss health care firm Novartis was honored by Fortune magazine as its Most Admired pharmaceutical company for 2011.It recieved an overall score of 7.02,folowed by Merck at 6.80 and Johnson&Johnson at 6.72.Last year,Novartis came in third.
The rank was decided by a survey of pharmaceutical executives,directors and analysts.They used nine criteria such as investment value and social responsibility.
Novartis is the world's third-largest pharmaceutical firm by sales.
One of its leading products is Gleevec(imatinib),a pill for patients with certain forms of chronic myeloid leukemia(CML) and gastrointestinal stromal tumors(GIST).Gleevec is also approved in the U.S.,EU and Japan for a form of acute lymphoblastic leukemia(ALL) and other blood disorders.It has helped many patients stay in remission for several years.
Novartis also owns the OTC brands Theraflu and Comtrex.The company has an assistance program for uninsured or underinsured patients.
Novartis AG(NVS)
No comments:
Post a Comment